Clinical studies recruiting near Waterbury

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Chase Medical Research, LLC · Kallyope Inc. · NCT07674654 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · St. Mary's Hospital · Agendia · NCT03053193 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT06769126 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · Alliance for Clinical Trials in Oncology · NCT06876714 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT05806515 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT05256225 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Chase Medical Research LLC · Novartis Pharmaceuticals · NCT07517263 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · ECOG-ACRIN Cancer Research Group · NCT07001748 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · NRG Oncology · NCT04852887 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT06058377 Change 4 Better (C4B)
NA · MCCA · Yale University · NCT06963931 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Smilow Cancer Hospital-Waterbury Care Center · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT05987241 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Chase Medical Research, LLC · Eli Lilly and Company · NCT07392190 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT04205968 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT05675410 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Chase Medical Research LLC · Amgen · NCT07136012 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT06616584 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT03723928 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · ECOG-ACRIN Cancer Research Group · NCT06475989 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT06422806 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT04267848 AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee
Phase 3 · Chase Medical Research LLC · Novo Nordisk A/S · NCT07509307 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · ECOG-ACRIN Cancer Research Group · NCT03937635 Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-
Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · NRG Oncology · NCT07166406 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Smilow Cancer Hospital-Waterbury Care Center · SWOG Cancer Research Network · NCT03851445 Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Out
Phase 2 · Smilow Cancer Hospital-Waterbury Care Center · National Cancer Institute (NCI) · NCT06050252

Look up another city

Look up another condition